Molecular mechanism of therapeutic approaches for human gastric cancer stem cells

doi:10.4252/wjsc.v14.i1.76

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 1

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6029)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

326

WORD

174

HTML

3026

Figures (1-3)

293

Tables (1-3)

290

Sum=4109

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

287

Download

646

Sum=933

Publishing Process of This Article

Item

Count

Browse

264

Download

723

Sum=987

Jan 26, 2022 (publication date) through Nov 19, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Stem Cells. Jan 26, 2022; 14(1): 76-91
Published online Jan 26, 2022. doi: 10.4252/wjsc.v14.i1.76

Table 2 Potential gastric cancer stem cells intracellular markers

Intracellular markers	Function	Physiological significance					Involved signaling pathways	Therapeutic targets	Prognostic marker of GC	Ref.
Intracellular markers	Function	Tumorigenicity/GCSC generation	Spheroid formation	Chemo-resistance	Radio-resistance	EMT/metastasis	Involved signaling pathways	Therapeutic targets	Prognostic marker of GC	Ref.
DOCK6	Dock-C subfamily guanine nucleotide exchanger	●	●	●	●	●	Wnt/β-catenin pathway	DOCK6	●	[50]
Mist1	Transcriptional factor	●	●	●	ND	●	Wnt/β-catenin pathway	Mist1	●	[51]
MSI-1	RNA-binding protein	●	●	●	ND	●	EGFR pathway	MSI-1	●	[48]
NANOG	Transcription factor	●	●	●	ND	●	Wnt/β-catenin pathwayJAK-STAT pathway	NANOG	●	[23,52]
Oct3/4	Octamer-binding transcription factor 3/4	●	●	●	ND	●	Wnt/β-catenin pathwayJAK-STAT pathway	Oct3/4	●	[23,53]
SOX2	Sex determining region Y-box 2	●	●	●	ND	●	Wnt/β-catenin pathwayJAK-STAT pathway	SOX2MiR-134all-trans retinoic acid	●	[52-57]

●: Determined; ND: Not determined; DOCK6: Dedicator of cytokinesis 6; Mist1: Muscle, intestine and stomach expression 1; MSI-1: Musashi RNA binding protein 1; GCSCs: Gastric cancer stem cells; GC: Gastric cancer; EMT: Epithelial–mesenchymal transition; NANOG: nanog homeobox; Oct3/4: Octamer-binding transcription factor 3/4; SOX2: Sex determining region Y-box 2; MAPK: Mitogen-activated protein kinase; ERK: Extracellular-signal-regulated kinase; JAK: Janus kinase; STAT3: Signal transducer and activator of transcription 3; EGFR: Epidermal growth factor receptor; miRNA: MicroRNA.

Citation: Hsieh HL, Yu MC, Cheng LC, Yeh TS, Tsai MM. Molecular mechanism of therapeutic approaches for human gastric cancer stem cells. World J Stem Cells 2022; 14(1): 76-91
URL: https://www.wjgnet.com/1948-0210/full/v14/i1/76.htm
DOI: https://dx.doi.org/10.4252/wjsc.v14.i1.76